Company Profile

LJL Biosystems Inc
Profile last edited on: 1/19/17      CAGE:       UEI:

Business Identifier: Assay automation system
Year Founded
1993
First Award
2000
Latest Award
2000
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

404 Tasman Drive
Sunnyvale, CA 94089
   (408) 541-8787
   N/A
   www.ljlbio.com
Location: Single
Congr. District: 17
County: Santa Clara

Public Profile

With the focus on development of bioanalytical measurement systems LJL Biosystems Inc had been in the business of design and production of tools primarily to pharmaceutical and biotechnology firms of infrastructure products to accelerate and enhance the process of discovering new drugs. The Company's proprietary integrated technology platform is comprised of instrumentation and consumables (microplates and fluorescence-based assay technologies) designed to provide flexible solutions to the current and evolving high throughput requirements of drug discovery laboratories.LJL Biosystems Inc was acquired by Molecular Devices Corporation (Nasdaq:MDCC) in August 2000 on a stock trade transaction.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : LJLB
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2000 1 NIH $98,341
Project Title: Fluorescence Polarization Assay of G-Protein Activation

Key People / Management

  John R Sportsman